Mr. Wu joined Temasek in October 2013 and is currently Joint Head, Portfolio Strategy & Risk Group and Joint Head, China.
Mr. Wu was previously President of CITIC Private Equity Funds Management, a position he held since December 2009. He concurrently served as Chairman and CEO of Goldstone Investment Co. Ltd., the direct investment arm of CITIC Securities.
Mr. Wu began his career with McKinsey, rising to become Senior Partner and Head of Asia Pacific M&A Practice. He was also General Manager of McKinsey Beijing, where he was responsible for providing M&A, corporate restructuring and IPO advisory for large Chinese enterprises. He had advised a number of leading Asian companies in their international expansion effort. He subsequently joined the Lenovo Group, and led the acquisition and integration of the IBM PC business, serving as Chief Strategy Officer, Chief Integration Officer, Chief Transformation Officer/ Chief Information Officer of Lenovo Group.
Mr. Wu was later appointed to Lenovo parent Legend Holdings, as Executive Vice President responsible for the overall business operations and overseeing its direct investment business.
Mr. Wu serves on the board of China Social Entrepreneur Foundation.
Mr. Wu holds a PhD in Biochemistry from Harvard University and a BSc. in Molecular Biology from University of Science and Technology of China.
Chong Wang, PhD
Intellectual Property Advisor
Dr. Chong Wang worked in the State Intellectual Property Office of China and patent agency for many years. She is proficient in both IP theory and practice. She was the head of IP department in Gan & Lee Pharmaceuticals and responsible for all domestic and international IP matters of the company. Under her leadership, the company’s core technology patent won the WIPO-SIPO award of Chinese outstanding patented invention, the brand name of company’s star product became the well-known trademark in Beijing, and the company received the certificate of both Beijing’s and National standard in “Enterprise Intellectual Property Management Practices”. On behalf of Gan & Lee Pharmaceuticals, she won several important patent litigations against major pharma companies.
Dr. Chong Wang holds a bachelor's degree of Pharmaceutical Science, a PhD of Biomedical Engineering from Peking University, and a bachelor's degree of Business Administration from Renmin University of China. She is a certified pharmacist and patent agent. She is also an expert panelist for Beijing’s IP court (qualified by the government to be on court panels for IP ruling).